AzTrials
AzTrials

Upper Crossed SyndromeNCT07773857

Comparison of Proprioceptive Neuromuscular Facilitation and Patient Education in Upper Crossed Syndrome

A study testing Patient Education and PNF in people with Upper Crossed Syndrome and Forward Head Posture, run by Atlas University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the effects of exercises applied using the Proprioceptive Neuromuscular Facilitation (PNF) technique on pain, joint range of motion, muscle strength, and posture in individuals with Upper Crossed Syndrome, and to compare these effects with patient education. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Patient Education and PNF
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 Mar 2026to 15 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Clinically diagnosed with Upper Crossed Syndrome and referred by a specialist physician (e.g., Physical Medicine and Rehabilitation, Orthopedics)
  • Upper Crossed Syndrome diagnosis confirmed at baseline based on postural characteristics (e.g., forward head posture, rounded shoulders, thoracic kyphosis etc.)
  • Willingness to participate in the study and provision of written informed consent

Who cannot join

  • History of spinal surgery or spinal fracture
  • Presence of structural spinal deformities (e.g., structural kyphosis or scoliosis)
  • Presence of neuromuscular diseases affecting the spine or upper quadrant
  • Presence of congenital or acquired severe structural spinal anomalies
  • Any medical condition that contraindicates participation in exercise programs
  • History of severe psychiatric disorders
Show all 9Show fewer
  • History of chronic pain in the cervical or lumbopelvic regions
  • History of postural control disorders
  • Any condition expected to prevent regular participation or adherence during the study period.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Atlas University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    Istanbul, Istanbul, 34408

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation and Comparison of the Effects of a Proprioceptive Neuromuscular Facilitation Technique and Patient Education on Pain, Range of Motion, Muscle Strength, and Posture in Individuals With Upper Crossed Syndrome

The aim of this study is to investigate the effects of exercises applied using the Proprioceptive Neuromuscular Facilitation (PNF) technique on pain, joint range of motion, muscle strength, and posture in individuals with Upper Crossed Syndrome, and to compare these effects with patient education. Individuals diagnosed with Upper Crossed Syndrome will be included in the study and allocated into two groups: a PNF-based exercise combined with patient education group and a patient education-only group.

In the PNF group, Stabilizing Reversals for scapular anterior elevation-posterior depression and Replication techniques for posterior depression will be applied. In the patient education group, education including postural awareness and exercise will be provided. Assessments will be conducted at two time points, before and after the intervention. Pain level, joint range of motion, muscle strength and endurance, and postural parameters will be analyzed.

This study is expected to provide evidence regarding the clinical effectiveness of PNF approaches targeting scapular control in individuals with Upper Crossed Syndrome and to contribute to the management of postural disorders in the field of physiotherapy and rehabilitation.

Being tested
Patient Education, PNF
Keywords
Upper Cross Syndrome, Proprioseptive Neuromuscular Facilitatiton, PNF, Patient Education, Posture
Medical subject headings
Oculocerebral hypopigmentation syndrome type Preus, Kyphosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient EducationBehavioural

    Participants in the patient education group will receive a single face-to-face patient education session at the beginning of the study. This education will include information on postural awareness, correct sitting posture, and maintaining proper posture during activities of daily living. In addition, participants will be provided with a prepared educational brochure and will be asked to perform the two postural exercises included in the brochure three days per week for a total duration of four weeks. Participants will be encouraged to integrate the postural principles taught during the education into their daily lives.

  • PNFBehavioural

    In the PNF, trunk correction in the sitting position, approximation, and the application of Stabilizing Reversals in the direction of scapular posterior depression-anterior elevation and Replication techniques toward scapular posterior depression in the side-lying position will be performed. These interventions are planned to be applied three days per week, with a total intervention duration of four weeks.

Study groups in NCT07773857
Study groupRoleWhat they receive
Patient Education GroupActive comparatorParticipants in the patient education group will receive a single face-to-face patient education session at the beginning of the study.
Receives: Behavioral: Patient Education
PNF GroupExperimentalIn the PNF group, in addition to patient education, Stabilizing Reversals and Replication techniques with scapular patterns will be performed.
Receives: Behavioral: Patient Education; Behavioral: PNF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Posture Assesment

    Posture will be assessed using the Posture Screen Mobile (PSM) application (Backbone Software, Inc., USA), a valid and reliable mobile application designed for postural analysis. Participants will be positioned in a static standing posture on a flat surface, with their feet parallel, wearing appropriate clothing that allows visualization of the upper body and lower extremities. Photographs will be taken from the anterior, posterior, and lateral views using a mobile device placed at a standardized distance.

    During the assessment, the application will automatically identify anatomical reference points (e.g., ears, shoulders, pelvis). Based on these reference points, postural deviations will be calculated and reported by the software. Anterior and posterior postural deviations in the frontal plane and lateral postural deviations in the sagittal plane will be recorded for each participant.

    Measured: Baseline and up to 8 weeks

Secondary outcomes (6)
  1. Muscle Strength Assessment

    Muscle strength of the thoracic back extensor muscles and abdominal muscles (upper, lower, and oblique abdominal muscles) will be assessed before and after the intervention using manual muscle testing performed by the same physiotherapist (Scoring 0-5).

    Upper abdominal muscle strength will be evaluated in the supine position using graded trunk flexion tasks with varying arm positions as resistance. Lower abdominal muscle strength will be assessed in the supine position by recording the ability to maintain lumbopelvic stability while the lower extremities are slowly lowered from 90° hip flexion. Oblique abdominal muscle strength will be evaluated through trunk flexion combined with rotation, with scoring based on movement quality and scapular clearance criteria.

    Measured: Baseline and up to 8 weeks

  2. Pain Assessment

    The level of back pain will be assessed using the Visual Analog Scale (VAS). The VAS consists of a 10-cm horizontal line, with the endpoints labeled "no pain" and "unbearable pain." Participants will be asked to mark the point on the scale that best represents the intensity of their pain. Pain intensity will be determined by measuring the distance in centimeters from the "no pain" anchor to the participant's mark.

    Measured: Baseline and up to 8 weeks

  3. Muscle Endurance

    Muscle endurance of the thoracic and lumbar back extensor muscles and the abdominal muscles (upper, lower, and oblique abdominal muscles) will be assessed. Endurance of the thoracic and lumbar back extensors will be evaluated using the Biering-Sorensen Test, a valid and reliable method for assessing isometric endurance of spinal extensor muscles. The duration for which the test position can be maintained will be recorded in seconds.

    Abdominal muscle endurance will be assessed by recording the holding time (in seconds) at the final position of the highest achievable manual muscle test score. Upper abdominal muscle endurance will be evaluated using the Bench Trunk Curl Test, oblique abdominal muscle endurance will be measured using the Flexion-Rotation Trunk Endurance Test, and lower abdominal muscle endurance will be assessed by recording the duration for which an isometric position requiring lumbopelvic stability can be maintained.

    Measured: Baseline and up to 8 weeks

  4. Muscle Length Tests

    Muscle length tests will be performed for the following muscle groups.

    Pectoralis Major (sternal and clavicular portions):

    Muscle length will be assessed in the supine position by measuring the distance between the lateral epicondyle of the humerus and the examination table on both sides. The upper limb will be positioned in shoulder external rotation with standardized abduction angles (135° for the sternal portion and 90° for the clavicular portion) and elbow extension. The measured distance will be recorded as an indicator of muscle tightness.

    Pectoralis Minor:

    Muscle length will be evaluated in the supine position by measuring the distance between the acromion and the examination table bilaterally. Greater distances will indicate increased muscle tightness.

    Hamstring Muscles:

    Hamstring muscle length will be assessed bilaterally using the straight leg raise test in the supine position. Hip flexion range of motion will be measured with a universal goniometer and recorded in degree

    Measured: Baseline and up to 8 weeks

  5. Range of Motion Assessment

    Trunk range of motion, including flexion, extension, lateral flexion, and rotation, will be assessed using a goniometric method. Measurements will be recorded in degrees using Saehan steel goniometers.

    Trunk flexion and extension will be measured in the standing position, with the goniometer aligned to anatomical landmarks of the lumbosacral region. Trunk lateral flexion will be assessed in standing, with the goniometer positioned to follow the spinal alignment. Trunk rotation will also be measured in the standing position, and the angle achieved during rotation will be recorded in degrees.

    Measured: Baseline and up to 8 weeks

  6. Flexibility Tests

    Trunk flexion flexibility will be assessed using the sit-and-reach test. Participants will be seated on a firm surface with the knees extended and instructed to reach forward toward their feet without bending the knees. The distance reached will be measured in centimeters using a measuring tape.

    Trunk extension, lateral flexion, and rotation flexibility will be assessed in the standing position. The distances achieved in the respective movement directions will be measured in centimeters using a measuring tape and recorded.

    Measured: Baseline and up to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start5 Mar 2026
  3. Primary completion15 Jun 2026
  4. Study completion15 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07773857
Sponsor's protocol ID
PNF_Patient_Edu
Status last verified
Jan 2026
First submitted
14 Aug 2026
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Patient Education and PNF in people with Upper Crossed Syndrome and Forward Head Posture, run by Atlas University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Posture Assesment (time frame: Baseline and up to 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in